[Calcium antagonists have a favorable long-term effect on lipid metabolism. Dr. K. P. Pollack presents results of his studies. Interview by Christine Schaefer].
Pollack
K P
KP
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D008055:Lipids; C035100:nilvadipine; D009543:Nifedipine
Kalziumantagonisten wirken langfristig günstig auf den Lipidstoffwechsel. Dr. K. P. Pollack erläutert seine Studienergebnisse.